Clinical Trials Browser

Nasopharyngeal Neoplasms

Ovarian Neoplasms

Urinary Bladder Neoplasms

ENSAT Stage I Adrenal Cortex Carcinoma

Lung Neoplasms

Lung Neoplasms

Leukemia, Lymphocytic, Chronic, B-Cell

Squamous Cell Cancer of Head and Neck (SCCHN)

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Multiple Myeloma

Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Nasopharyngeal Neoplasms

Mesothelioma, Malignant, Mesothelioma

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Recurrence, Testicular Neoplasms, Seminoma

Triple Negative Breast Neoplasms

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

Nasopharyngeal Cancinoma (NPC)

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

Biliary Tract Neoplasms

Multiple Myeloma

Neoplasms, Germ Cell and Embryonal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Sarcoma, Osteosarcoma

Radiation Injuries, Disease Progression

Nasopharyngeal Neoplasms

Hepatoblastoma

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Cholangiocarcinoma

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Penile Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Carcinoma, Non-Small-Cell Lung, Neoplasms

Clinical Trials

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

OVHIPEC-2

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Auto-LLC 2001

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

RePaIr-HN

NIRVANA-LUNG

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

SHINE

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

DREAM3R

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

SWENOTECA-ABC

SASCIA

UPFRONT-NECK

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Lysari

SALTORL

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

NAUTICAL

DIAMOND

TAB-2

TT4B

P3BEP

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

OS2006

Omitting CTV for Primary Tumor in LS-SCLC

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

SANTAL

REACH

NIVOPOSTOP

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

SAFIR-ABC10

ARIAN

InPACT

ACTICCA-1

EURTAC